Immunohistochemistry was performed to detect the expression of VEGFR-2 and TGF-β in the microenvironment of fast-flow (arteriovenous malformations (n = 10) and slow-flow malformations (venous (n = 6) and lymphatic malformations (n = 4)). This evidence concerns the gene TGFB1 and lymphatic malformation.